Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2001

Shao Z M, Wu J, Shen Z Z, Nguyen M

Abstract excerpt

PURPOSE: Tumor-specific DNA has recently been detected in the plasma of lung, head and neck, breast, and colon cancer patients. Detection of tumor-specific genetic materials in cancer patients at sites distant from the tumor, such as in the blood, may provide a unique and valuable tumor marker fo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoembryonic Antigen
Share to DNA, Neoplasm
Share to Mucin-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Polymorphism, Single-Stranded Conformational

Share to Survival Analysis

Source

Identifiers

PMID: 11489795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11489795-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.PMID 11489795Read ↗

[Peripheral blood mutated p53 DNA and its clinical value in human breast cancer].Semantic proximity Read ↗

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients.Semantic proximity Read ↗

Clinical factors associated with circulating tumor <scp>DNA</scp> (ct<scp>DNA</scp>) in primary breast cancerSemantic proximity Read ↗

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.Semantic proximity Read ↗

TP53 gene mutations in plasma DNA of cancer patients.Semantic proximity Read ↗

Tumor-specific DNA in plasma of breast cancer patients.Semantic proximity Read ↗

Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.Semantic proximity Read ↗

Prognostic value of p53 molecular status in high-risk primary breast cancer.Semantic proximity Read ↗

Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic ToolSemantic proximity Read ↗

TP53 gene in blood plasma DNA of tumor patients.Semantic proximity Read ↗

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistrySemantic proximity Read ↗

Microsatellite alterations plasma DNA of primary breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.